Characterization, Molecular Modeling and Pharmacology of Some 2́-hydroxychalcone Derivatives As SARS-CoV-2 Inhibitor
Overview
Authors
Affiliations
This work presented the microwave assisted synthesis of six new 2́-hydroxychalcones and their characterization based on FTIR, UV-Vis, H NMR, and mass spectral analysis. Quantum chemical studies confirmed the structures of prepared chalcones. Antioxidant, antimicrobial and antiviral studies have been performed to evaluate their biological performance. Results of molecular docking of prepared 2́-hydroxychalcones against SARS-CoV-2 (7BQY) main protease disclosed their inhibition which is comparable to standard, remdesivir and better than hydroxychloroquine (HCQ). ADMET prediction revealed them to be non-carcinogenic and relatively safe.
Sreekandan S, Thadathil A, Mavila B, Vellayan K, Periyat P RSC Adv. 2025; 15(6):4553-4561.
PMID: 39931406 PMC: 11808485. DOI: 10.1039/d4ra05486e.
Nafie M, Hamza A, Moustafa A, El-Sayed H, El Rayes S, Morsy H RSC Adv. 2024; 14(53):39381-39394.
PMID: 39679418 PMC: 11638703. DOI: 10.1039/d4ra07963a.
Naeem N, Sadiq A, Othman G, Yassin H, Mughal E RSC Adv. 2024; 14(48):35769-35970.
PMID: 39534850 PMC: 11555472. DOI: 10.1039/d4ra06290f.
The role of silicon in drug discovery: a review.
Panayides J, Riley D, Hasenmaile F, van Otterlo W RSC Med Chem. 2024; 15(10):3286-3344.
PMID: 39430101 PMC: 11484438. DOI: 10.1039/d4md00169a.
Rueda-Espinosa J, Ramanayake D, Ball N, Love J Can J Chem. 2024; 101(10):765-772.
PMID: 38550267 PMC: 10978044. DOI: 10.1139/cjc-2023-0033.